» Articles » PMID: 34133027

Cerebral Venous Thrombosis Post BNT162b2 MRNA SARS-CoV-2 Vaccination: A Black Swan Event

Citing Articles

Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review.

Satyam S, El-Tanani M, Bairy L, Rehman A, Srivastava A, Kenneth J Cardiovasc Toxicol. 2025; 25(2):306-323.

PMID: 39826014 DOI: 10.1007/s12012-024-09954-2.


Persistently High Platelet Factor 4 Levels in an Adolescent with Recurrent Late Thrombotic Complications after SARS-CoV-2 mRNA Vaccination.

Haga Y, Ohara A, Yakuwa T, Yamashita A, Udo M, Matsuoka M Hematol Rep. 2024; 16(3):504-511.

PMID: 39189244 PMC: 11348110. DOI: 10.3390/hematolrep16030048.


Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.

Chung Y, Lam C, Tan P, Tsang H, Wong S Int J Mol Sci. 2024; 25(15).

PMID: 39125722 PMC: 11312261. DOI: 10.3390/ijms25158155.


Risk of pulmonary embolism and deep vein thrombosis following COVID-19: a nationwide cohort study.

Kim H, Jeong S, Song J, Park S, Park Y, Oh Y MedComm (2020). 2024; 5(7):e655.

PMID: 39006761 PMC: 11246596. DOI: 10.1002/mco2.655.


Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS).

Yousaf Z, Ata F, Mohammed Hammamy R Thromb Update. 2024; 7:100104.

PMID: 38620755 PMC: 9013693. DOI: 10.1016/j.tru.2022.100104.


References
1.
Buzhdygan T, DeOre B, Baldwin-Leclair A, Bullock T, McGary H, Khan J . The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 2020; 146:105131. PMC: 7547916. DOI: 10.1016/j.nbd.2020.105131. View

2.
Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein E, Brodsky R . Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 2020; 136(18):2080-2089. PMC: 7596849. DOI: 10.1182/blood.2020008248. View

3.
Smadja D, Yue Q, Chocron R, Sanchez O, Lillo-Le Louet A . Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. Eur Respir J. 2021; 58(1). PMC: 8051185. DOI: 10.1183/13993003.00956-2021. View

4.
Probst J, Weide B, Scheel B, Pichler B, Hoerr I, Rammensee H . Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Ther. 2007; 14(15):1175-80. DOI: 10.1038/sj.gt.3302964. View

5.
Dias L, Soares-Dos-Reis R, Meira J, Ferrao D, Soares P, Pastor A . Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis. 2021; 30(8):105906. PMC: 8148614. DOI: 10.1016/j.jstrokecerebrovasdis.2021.105906. View